Results 151 to 160 of about 5,576,143 (310)

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Interpolating gauge-fixing for Yang–Mills–Chern–Simons theory in $$D=3$$ D = 3

open access: yesEuropean Physical Journal C: Particles and Fields
The Yang–Mills–Chern–Simons theory in three-dimensional Minkowski space-time is studied in a gauge-fixing scheme which interpolates between the covariant gauge and light-cone gauge, the interpolating gauge-fixing. The ultraviolet finiteness of the theory
Daniel O. R. Azevedo   +3 more
doaj   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Light scalar spectrum in extra-dimensional gauge theories [PDF]

open access: yes, 2012
The phase diagram of five-dimensional SU(2) gauge theories with one compactified dimension on anisotropic lattices has a rich structure. In this contribution we show how to control non-perturbatively the scale hierarchy between the cut-off and the ...
Rinaldi, Enrico   +2 more
core  

Quantum gravity from Weyl conformal geometry

open access: yesEuropean Physical Journal C: Particles and Fields
We review recent developments in physical implications of Weyl conformal geometry. The associated Weyl quadratic gravity action is a gauge theory of the Weyl group of dilatations and Poincaré symmetry.
D. M. Ghilencea
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Shortening the gauge argument [PDF]

open access: yes, 2012
The ``gauge argument'' is often used to `deduce' interactions from a symmetry requirement. A transition---whose justification can take some effort---from global to local transformations is typically made at the beginning of the argument.
Afriat, Alexander, Alexander Afriat
core  

Quantization of galilean gauge theories

open access: yesLettere Al Nuovo Cimento Series 2, 1983
Galilean gauge theories are quantized using Dirac’s theory of canonical quantization of constrained systems. The infra-red sector for the Abelian case is exactly solved and shown to be analogous to that of the relativistic case.
openaire   +3 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy